Simplex Trading
RLMD icon

Simplex Trading’s Relmada Therapeutics RLMD Stock Holding History

Simplex Trading’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$182K Buy
+26,200
New +$124K ﹤0.01% 4410
2024
Q4 		– Sell
-11,200
Closed -$36K – 9456
2024
Q3 		$36K Buy
11,200
+4,400
+65% +$14.3K ﹤0.01% 6195
2024
Q2 		$20K Buy
6,800
+5,600
+467% +$20.3K ﹤0.01% 6904
2024
Q1 		$5K Sell
1,200
-51,400
-98% -$248K ﹤0.01% 8035
2023
Q4 		$217K Buy
52,600
+4,400
+9% +$13K ﹤0.01% 4599
2023
Q3 		$144K Sell
48,200
-3,700
-7% -$11K ﹤0.01% 4708
2023
Q2 		$127K Buy
+51,900
New +$143K ﹤0.01% 4795
2023
Q1 		– Sell
-8,000
Closed -$27K – 9959
2022
Q4 		$27K Sell
8,000
-126,000
-94% -$1.11M ﹤0.01% 6586
2022
Q3 		$4.96M Sell
134,000
-23,900
-15% -$662K 0.01% 1215
2022
Q2 		$3M Buy
157,900
+105,400
+201% +$2.3M ﹤0.01% 1501
2022
Q1 		$1.42M Buy
+52,500
New +$1.09M ﹤0.01% 2477
2021
Q4 		– Sell
-2,700
Closed -$90K – 11296
2021
Q3 		$90K Hold
2,700
– – ﹤0.01% 6768
2021
Q2 		$86K Buy
2,700
+2,679
+12,757% +$93.1K ﹤0.01% 6947
2021
Q1 		$73K Buy
21
+20
+2,000% +$700 ﹤0.01% 6158
2020
Q4 		$3K Hold
1
– – ﹤0.01% 7898
2020
Q3 		$3K Buy
+1
New +$39 ﹤0.01% 7313

Other funds holding RLMD

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
SSC
Spruce Street Capital New York $416M AUM
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Simplex Trading's RLMD Position: Q1 2026 in Review

Simplex Trading sold out of Relmada Therapeutics (RLMD) in Q1 2026, closing a stake of 18,611 shares — an estimated $88.1K sold.

Simplex Trading first reported a position in RLMD in Q4 2019 and held it in 18 quarters. The position peaked at $290K in Q1 2021. 103 funds tracked by Wall St. Rank hold RLMD as of Q1 2026.

  • Simplex Trading reported no remaining Relmada Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 18,611 Relmada Therapeutics shares in Q1 2026, an estimated $88.1K.
  • Simplex Trading first reported a position in Relmada Therapeutics in Q4 2019 and held it in 18 quarters.
  • Simplex Trading's Relmada Therapeutics position peaked at $290K in Q1 2021.
  • 103 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.